News|Radiation Oncology| May 21, 2020

New features help clients safeguard care teams and cancer patients, proactively communicate, and ensure access to care

In response to the significant healthcare delivery changes brought on by COVID-19, Varian has launched new capabilities for its Noona software application, a powerful tool designed to engage cancer patients in their care for continuous reporting and symptom monitoring.

May 21, 2020 — In response to the significant healthcare delivery changes brought on byCOVID-19,Varianhas launched new capabilities for itsNoona software application,一个强大的工具,旨在参与癌症患者在他们的护理持续报告和症状监测。Noona通过提供应用程序内的功能,如患者筛查、实时症状报告、安全护理团队消息、电话分诊工作流程自动化以及患者访问医疗记录,为癌症护理团队提供短期和长期医疗保健新变化。此外,Varian还设计了一种新的方法,可以快速和远程实施解决方案,更快地将其交到癌症患者和护理团队手中,而不会增加感染COVID-19的风险。

"In light of COVID-19 and the difficulties it poses to the current state of cancer care delivery, cancer patients are more vulnerable than ever," saidJeff Patton, M.D., executive chairman, Tennessee Oncology – one of the nation's largest community-based cancer care groups – and CEO, OneOncology. "Now more than ever, we need solutions to remotely communicate with and manage our patients to protect them and our team who cares for them. Noona is an invaluable solution for facing the results of the pandemic, and we are confident it will serve as a strong foundation in the new care landscape for clinicians and patients well into the future."

Noona has made a positive impact on care offered byTennessee Oncology, with nearly 600 care team members using Noona; around 10,000 patients accessing the Noona patient app to report symptoms and communicate with clinicians; and about 31,000 patients being managed through the telephone triage workflow automation. Like other clients, Tennessee Oncology is experiencing even more demand for the Noona patient app with patient adoption steadily increasing by about 1,000 new patients a month since the beginning of the pandemic.

"Telemedicine and digital communication are here to stay, so do it now and do it forever," Patton advised. "Noona has helped us reduce the risk of exposure for patients and staff, while keeping our healthcare communities fully informed. Since the COVID-19 outbreak first hit, we've found our 'new abnormal' and at the moment it's stable so we can function in a steady state."

"Solutions like Noona have proven their ability to reduce emergency room visits, and with the altered state of healthcare brought on by COVID-19, the value that Noona offers has never been more needed," saidJani Ahonala, vice president, global patient outcomes, at Varian. "When the current pandemic began, we reprioritized our team's daily activities to quickly help our customers and patients across the globe."

The Varian product team quickly developed and released a new COVID-19-related symptom screening questionnaire. A series of questions specific to COVID-19 symptoms, as defined by the World Health Organization and Centers for Disease Control and Prevention, guides the process and taps into severity grading options that, via a back-end algorithm, will alert the cancer clinic with a "Red" or High Alert status, allowing care teams to act quickly.

Due to the many new requests for the Noona solution from other cancer care organizations, the team also reengineered the implementation process to remotely and quickly get other clinics up and running. The new rapid deployment process allows solution experts to configure and set up an entirely new cancer organization and virtually train care team users through video conferencing tools and pre-built education materials – in just a few weeks' time without being onsite.

For more information:www.varian.com

Related Content

Research has potential to address significant unmet need, identify biomarkers that determine response to treatment
News|Lung Imaging

August 10, 2022 — Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 ...

TimeAugust 10, 2022
arrow
位于奥马哈的MRI医疗器械公司Bot Image开发了一款人工智能驱动的医疗器械CAD软件,可以显著提高前列腺癌检测(CADe)和诊断(CADx)的准确性和速度。
News|Prostate Cancer

August 9, 2022 — Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD ...

TimeAugust 09, 2022
arrow
The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with unresectable (unable to be removed) or metastatic (spread to other parts of the body) HER2-low breast cancer.
News|2022世界杯篮球预选赛赛程

August 8, 2022 — The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV ...

TimeAugust 08, 2022
arrow
Dr. Milena Cavic, Institute for Oncology and Radiology of Serbia
News|Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

TimeAugust 08, 2022
arrow
David Gerber, MD
News|Lung Imaging

August 8, 2022 — A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill ...

TimeAugust 08, 2022
arrow
Under this collaboration, IBA will equip the proton therapy system and the proton gantry treatment room at the Fred Hutchinson Cancer Center with ConformalFLASH research functionality, which will enable preclinical research on FLASH therapy.
News|Proton Therapy

August 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, Fred ...

TimeAugust 05, 2022
arrow
Enhancing oncology model aims to improve patient-centered care, lower health care costs, and address health equity as part of President Biden’s Cancer Moonshot
News|Radiology Business

August 4, 2022 — The Biden Administration, through the U.S. Department of Health and Human Services and the Centers for ...

TimeAugust 04, 2022
arrow
News|世界杯2022赛程时间表

August 3, 2022 — The Jack Martin Fund (JMF) has built on its partnership with the Mount Sinai Health System to provide ...

TimeAugust 03, 2022
arrow
The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to grow to $5.4 Bn by 2032, at a CAGR of 7.8% from 2022 to 2032.
Feature|Oncology Information Management Systems (OIMS)

August 2, 2022 — The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to ...

TimeAugust 02, 2022
arrow
The American Lung Association created LUNG FORCE, a national movement to defeat lung cancer, the leading cancer killer of women and men.
Feature|Lung Imaging

August 1, 2022 — In recognition of World Lung Cancer Day, the American Lung Association announced new patient resources ...

TimeAugust 01, 2022
arrow
Subscribe Now